Onconova (ONTX) Enters Oversold Territory - Tale of the Tape

by Zacks, Benzinga Contributor

April 4, 2014 10:05 AM | 1 min read | Make a Comment

Onconova Therapeutics Inc. 's ONTX share price has entered into oversold territory with an RSI value of 19.3. The Zacks Consensus Estimate for Onconova for the full year period has improved 75 cents over the past two months to $-2.09 per share. Currently, Onconova has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on ONTX after its recent drop.

ONCONOVA THERAP ONTX: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!